Mounjaro sales double this year as obesity drug boom prevails, says maker Evening Standard 2d Article paywall
Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer PR Newswire (Press Release) 5d
Abbott laboratories vs. Eli Lilly: Which healthcare stock is a better buy in 2026? The Motley Fool 6d
Watch out, Eli Lilly and Novo Nordisk: Amgen's monthly weight loss drug has 6 Phase 3 trials running -- and it's coming for your patients The Motley Fool 12:59 Wed, 29 Jul
Meet the stock that's obliterating Eli Lilly, Johnson & Johnson, and AbbVie right now The Motley Fool 22:17 Wed, 29 Jul